Mycobacterium avium infection in BALB/c and SCID mice

Journal of Medical Microbiology

Volumn 48, Issue 6, 1999, Pages 577-583

  Fattorini, Lanfranco ^a   Mattei, Maurizio ^b   Placido, Roberta ^c   Li, Bo ^a,d   Iona, Elisabetta ^a   Agrimi, Umberto ^a   Colizzi, Vittorio ^b   Orefici, Graziella ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BACTERIOSTASIS; BRAIN; COLONY FORMING UNIT; CONTROLLED STUDY; EXPERIMENTAL INFECTION; GRANULOMA; KIDNEY; LIVER; LUNG; MACROPHAGE; MALE; MONONUCLEAR CELL; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NATURAL KILLER CELL; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; SCID MOUSE; SPLEEN; T LYMPHOCYTE;

EID: 0032827989     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-48-6-577     Document Type: Article

References (27)

1. 1. Inderlied CB, Kemper CA, Bermudez LEM. The Mycobacterium avium complex. Clin Microbiol Rev 1993; 6: 266-310.
2. 2. Bancroft GJ, Kelly JP. Macrophage activation and innate resistance to infection in SCID mice. Immunobiology 1994; 191: 424-431.
3. 3. Kaufmann SHE. Immunity to intracellular microbial pathogens. Immunol Today 1995; 16: 338-342.
4. 4. Appelberg R, Castro AG, Pedrosa J, Silva RA, Orme IM, Minóprio P. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infect Immun 1994; 62: 3962-3971.
5. 5. Saunders MB, Cheers C. Inflammatory response following intranasal infection with Mycobacterium avium complex: role of T-cell subsets and gamma interferon. Infect Immun 1995; 63: 2282-2287.
6. 6. Harshan KV, Gangadharam PRJ. In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice. Infect Immun 1991; 59: 2818-2821.
7. 7. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301: 527-530.
8. 8. Perryman LE, Mason PH, Chrisp CE. Effect of spleen cell populations on resolution of Cryptosporidium parvum infection in SCID mice. Infect Immun 1994; 62: 1474-1477.
9. 9. North RJ, Izzo AA. Granuloma formation in severe combined immunodeficient (SCID) mice in response to progressive BCG infection. Tendency not to form granulomas in the lung is associated with faster bacterial growth in this organ. Am J Pathol 1993; 142: 1959-1966.
10. 10. North RJ, Izzo AA. Mycobacterial virulence. Virulent strains of Mycobacterium tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity. J Exp Med 1993; 177: 1723-1733.
11. l T cells. Int Immunol 1996; 8: 1299-1310.
12. 12. Fattorini L, Vincent V, Li B et al. Type frequency and antimicrobial susceptibility of Mycobacterium avium-intracellulare complex strains isolated in Italy from AIDS and non AIDS patients. J Chemother 1996; 173: 1030-1034.
13. 13. Torriani FJ, Behling CA, McCutchan JA, Haubrich RH, Havlir DV. Disseminated Mycobacterium avium complex: correlation between blood and tissue burden. J Infect Dis 1996; 173: 942-949.
14. 14. Wong B, Edwards FF. Kiehn TE et al. Continuous high-grade Mycobacterium avium-intracellulare bacteremia in patients with acquired immune deficiency syndrome. Am J Med 1985; 78: 35-40.
15. 15. Ferreira P, Soares R, Arala-Chaves M. Susceptibility to infection with Mycobacterium avium is paradoxically correlated with increased synthesis of specific anti-bacterial antibodies. Int Immunol 1991; 3: 445-452.
16. 16. Vordermeier HM, Venkataprasad N, Harris DP, Ivanyi J. Increase of tuberculosis infection in the organs of B cell-deficient mice. Clin Exp Immunol 1996; 106: 312-316.
17. 17. Hakim A, Hisam N, Reuman PD. Environmental mycobacterial peritonitis complicating peritoneal dialysis: three cases and review. Clin Infect Dis 1993, 16: 426-431.
18. 18. Harro C, Braden GL, Morris AB, Lipkowitz GS, Madden RL. Failure to cure Mycobacterium gordonae peritonitis associated with continuous ambulatory peritoneal dialysis. Clin Infect Dis 1997; 24: 955-957.
19. 19. Perazella M, Eisen T, Brown E. Peritonitis associated with disseminated Mycobacterium avium complex in an acquired immunodeficiency syndrome patient on chronic ambulatory peritoneal dialysis. Am J Kidney Dis 1993; 21: 319-321.
20. 20. Adal KA, Wispelwey B. Mycobacterium avium complex peritonitis in a patient with alcoholic liver disease. J Clin Gastroenterol 1996; 22: 245-246.
21. 21. Fernandez-Miranda C, Medina J, Palenque E, Martinez-Antonio E, Gonzalez-Gomez C. Peritonitis with Mycobacterium avium in a patient with hepatic cirrhosis. Am J Gastroenterol 1993; 88: 615.
22. 22. Perlino CA. Mycobacterium avium complex: an unusual cause of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Clin Inf Dis 1993; 17: 1083-1084.
23. 23. Hopewell PC. Overview of clinical tuberculosis. In: Bloom BR (ed) Tuberculosis: pathogenesis, protection, and control. Washington, DC, ASM Press. 1994: 25-46.
24. 24. Nance FC. Diseases of the peritoneum, retroperitoneum, mesentery, and omentum. In: Haubrich WS, Schaffner F, Berk JE (eds) Bockus Gastroenterology, 5th edn, vol 4. Philadelphia, WB Saunders. 1995: 3061-3105.
25. 25. Eischen A, Duclos B, Schmitt-Goguel M et al. Human resident peritoneal macrophages; phenotype and biology. Br J Haematol 1994; 88: 712-722.
26. 26. Appelberg R, Sarmento AM. The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice. Clin Exp Immunol 1990; 80: 324-331.
27. 27. Barnes PF, Modlin RL, Ellner JJ. T-cell responses and cytokines. In: Bloom BR (ed) Tuberculosis: pathogenesis, protection and control. Washington, DC, ASM Press. 1994: 417-435.